SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-065536
Filing Date
2021-05-13
Accepted
2021-05-13 08:30:40
Documents
4
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2114944d1_def14a.htm DEF 14A 376512
2 GRAPHIC tm2114944d1_pre14aimg002.jpg GRAPHIC 4713
3 GRAPHIC tm2114944d1_pre14aimg003.jpg GRAPHIC 351346
4 GRAPHIC tm2114944d1_pre14aimg004.jpg GRAPHIC 158778
  Complete submission text file 0001104659-21-065536.txt   1087173
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 21917347
SIC: 2834 Pharmaceutical Preparations